Table 3.
Decreasing LogCFR and risk for adverse outcomes (unadjusted Cox regression analyses)
All women | |||
---|---|---|---|
Outcome | Hazard Ratio | 95% CI | p |
Major adverse outcome (death, nonfatal MI, nonfatal stroke, or hospitalization for CHF) | 1.16 | 1.04 – 1.30 | 0.009 |
CV death, nonfatal MI, nonfatal stroke, or hospitalization for CHF | 1.15 | 1.02 – 1.30 | 0.019 |
CV death, nonfatal MI, or hospitalization for CHF | 1.18 | 1.03 – 1.36 | 0.018 |
Women without obstructive CAD | |||
---|---|---|---|
Outcome | Hazard Ratio | 95% CI | p |
Major adverse outcome (death, nonfatal MI, nonfatal stroke, or hospitalization for CHF) | 1.20 | 1.05 – 1.38 | 0.008 |
CV death, nonfatal MI, nonfatal stroke, or hospitalization for CHF | 1.19 | 1.03 – 1.37 | 0.020 |
CV death, nonfatal MI, or hospitalization for CHF | 1.23 | 1.03 – 1.47 | 0.021 |
MI=myocardial infarction; CHF=congestive heart failure; CV=cardiovascular; CI=confidence interval.